First Trust Direct Indexing’s Braskem BAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-10,174
Closed -$89.7K 814
2023
Q4
$89.7K Sell
10,174
-1,762
-15% -$13.5K 0.01% 745
2023
Q3
$98K Sell
11,936
-260
-2% -$2.52K 0.01% 680
2023
Q2
$142K Sell
12,196
-8,173
-40% -$77.4K 0.02% 675
2023
Q1
$157K Buy
20,369
+1,208
+6% +$9.8K 0.02% 660
2022
Q4
$176K Buy
19,161
+1,508
+9% +$16.8K 0.02% 639
2022
Q3
$172K Sell
17,653
-1,426
-7% -$17.8K 0.03% 597
2022
Q2
$272K Buy
19,079
+6,552
+52% +$112K 0.04% 498
2022
Q1
$234K Buy
12,527
+1,549
+14% +$29.3K 0.03% 579
2021
Q4
$232K Buy
10,978
+138
+1% +$2.74K 0.03% 564
2021
Q3
$237K Sell
10,840
-102
-0.9% -$2.36K 0.03% 544
2021
Q2
$261K Buy
+10,942
New +$218K 0.04% 494

Other funds holding BAK

First Trust Direct Indexing's BAK Position: Q1 2024 in Review

First Trust Direct Indexing sold out of Braskem (BAK) in Q1 2024, closing a stake of 10,174 shares — an estimated $89.7K sold.

First Trust Direct Indexing first reported a position in BAK in Q2 2021 and held it in 11 quarters. The position peaked at $272K in Q2 2022. 50 funds tracked by Wall St. Rank hold BAK as of Q1 2024.

  • First Trust Direct Indexing reported no remaining Braskem position as of Q1 2024 after selling out during the quarter.
  • First Trust Direct Indexing sold 10,174 Braskem shares in Q1 2024, an estimated $89.7K.
  • First Trust Direct Indexing first reported a position in Braskem in Q2 2021 and held it in 11 quarters.
  • First Trust Direct Indexing's Braskem position peaked at $272K in Q2 2022.
  • 50 funds tracked by Wall St. Rank held Braskem as of Q1 2024.

Based on First Trust Direct Indexing's 13F filing for Q1 2024, filed 19 Apr 2024.